We're thrilled to be named one of Europe's top ten most promising biopharma startups by EU-Startups. We remain dedicated to advancing the field and making a positive impact.
Biopharma represents a dynamic sector that offers targeted and precise treatments for complex diseases at a molecular level, often with fewer side effects compared to conventional drugs 🌟🔬 Unlike traditional #pharmaceuticals, which are typically synthesised chemically, #biopharma products are derived from living organisms such as cells, tissues, or proteins. This involves a significant amount of #technology, #innovation, and of course #investment💡💰 On that note, we have curated a list of 10 promising biopharma startups in Europe that are at the forefront of this innovation. These companies, all founded between 2019 and 2024, are advancing scientific knowledge and developing groundbreaking treatments that have the potential to transform healthcare globally. Accession Therapeutics Limited, Adendra Therapeutics, Cellcolabs, Multiomic Health, Muna Therapeutics Neurosterix Nuage Therapeutics Ochre Bio, Quercis Pharma, Cimeio Therapeutics https://lnkd.in/dVeUhW8p